Three Companies That Are Just as Great as Gilead (GILD)
Amgen (AMGN) Releases Secret Data on Three Failed Studies to Confirm Findings in High Profile Journals
Shkreli's E-Trade Account Has Lost $40 Million, New Lawyer Orders "Pharma Bro" to Zip It
Two Biopharma Female Execs Pen Open Letter Opposing Firms that Hire Models for Industry Parties
Agilent (A) Sues San Francisco Startup Twist Bioscience Over Trade Secrets and Poached Employees
Amidst Allegations of Financial Misconduct, Osiris (OSIR) CEO Resigns
Emerging from Stealth Mode to Prevent Diseases of Aging, Unity Biotechnology to Double Hiring in Bay Area
Regeneron (REGN) Stock Rocks, but Vertex (VRTX), Medivation (MDVN) & Jazz Pharma (JAZZ) Roll
GlaxoSmithKline (GSK) CEO Asks Investors to Give Him Three Years to Turn Around Consumer Health Unit Before Considering a Break Up
Johnson & Johnson (JNJ) Hands Over In-House Rival BetaLogics to ViaCyte, Gives Updates on Stem Cell Diabetes Trial
Gilead (GILD) May Take Page Out of Pfizer (PFE)'s Game Plan as Firm Hunts for M&As to Sustain Growth
Bay Area's Pacific Biosciences (PACB) Stock Pops on Roche (RHHBY) Acquisition Bid Rumors
Deal Spree for AstraZeneca PLC (AZN) Pretty Much Over as CEO Says "We Have What We Need to Have"
Stop Using BMI To Determine Whether People Are Healthy, University of California, Los Angeles (UCLA)-Led Study Says
Misery Of Work Second Only To Illness, University Of Sussex Study
Takeda (TKPYY) Wagers $1 Billion+ More on Mersana Therapeutics' Antibody Program
New Perk Discovered In Bilingual Speakers, Concordia University Study
Destroying Worn-Out Cells May Extend Your Life, Mayo Clinic Study
See All News >